Related Experiment Video
Updated: May 10, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Refusal of treatment for acute leukemia in pregnancy: a case report
Syheda Latifi Hoxha1, Vlora Ademi Ibishi, Ahmet Brovina
1Obstetrics and Gynecology Clinic, University Clinical Center of Kosova, Prishtina, 10000, Kosova. drsyheda@yahoo.com.
Introduction:
Acute leukemia is rare in pregnancy. The importance of promptly diagnosing and treating this disease in pregnancy stems from its life-threatening potential, both to the mother and fetus.
Case Presentation:
We report a case of relapse of acute myeloid leukemia at 23 weeks of pregnancy in a 24-year-old Albanian woman. Our patient categorically refused chemotherapy treatment, and in her 35th week of gestation, severe hemorrhagic diathesis rapidly developed. The manifestation and course of this life-threatening complication posed therapeutic challenges for the attending medical team.
Conclusion:
Based both on our experience and the results of other gynecological studies, there exists a strong indication that the earlier a patient's chemotherapy treatment begins, the better the maternal outcome. We support chemotherapy for patients who are pregnant presenting with such illness. The present case report testifies that refusal of chemotherapy by such patients is a high-risk decision.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Treatment Resistent Cancers
Treatment Resistant Cancers
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management